22UAY.DE (22UAY.DE) News
Follow 22UAY.DE (22UAY.DE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BioNTech CEO Uğur Şahin reports disposal of USD 6.24 million in common shares
BioNTech CEO Ugur Sahin sold 64,000 ordinary shares on Sept. 17-18, 2026 at USD 96.22 to USD 98.6. Direct holdings fell to 489,209 shares following the transactions. Disclaimer: This news brief was created by Public Tech
REGULATION | Sep 18, 2026, 08:47 PM UTC
L
BioNTech names KPMG as independent auditor for FY2027
BioNTech named KPMG as independent auditor for the financial year ending Dec. 31, 2027, pending shareholder election at its AGM. The audit committee ran a competitive tender process, then recommended KPMG; the supervisor
REGULATION | Sep 18, 2026, 08:12 PM UTC